Document is current
Any future updates will be listed below
-
Authors
Makras, Polyzois https://orcid.org/0000-0002-3231-3357
Yavropoulou, Maria P. https://orcid.org/0000-0002-6501-3692
Polyzos, Stergios A. https://orcid.org/0000-0001-9232-4042
Papapoulos, Socrates E. https://orcid.org/0000-0003-2243-6940
Georgakopoulou, Danai
Papatheodorou, Athanasios
Anastasilakis, Athanasios D. https://orcid.org/0000-0002-9624-6296
- License Information
-
More Information
Article History
Received: 25 April 2023
Accepted: 25 September 2023
First Online: 2 October 2023
Declarations
:
: All procedures performed in the study were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Polyzois Makras reports fees for lectures/advisory boards and research grants from Amgen and Galenica and fees for lectures/advisory boards from UCB, Elpen, Bianex, Eli-Lilly, ITF, Unipharma, and Rapharm; Maria P. Yavropoulou reports fees for lectures/advisory boards and research grants from Galenica; Socrates E. Papapoulos reports consulting/speaking fees from Amgen, Entera Bio, Qualix Dot, Radius Health and UCB; Athanasios D. Anastasilakis reports lecture fees from Amgen, Bianex, Eli-Lilly, Galenica, ITF, Unifarma, and UCB; Stergios A. Polyzos, Danai Georgakopoulou and Athanasios Papatheodorou have nothing to declare.
